Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wenzhou Kangning Hospital CoFRA:4WK +1.63%75 Debt-to-EBITDA is 10.93 as of Jun. 2026, which is 89% above its 10-year median of 5.77. GuruFocus rates FRA:4WK with a GF Score™ of 75/100 and a GF Value™ of €1.35. The stock has 2 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Wenzhou Kangning Hospital Co ranks worse than 88.75% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Wenzhou Kangning Hospital Co's Debt-to-EBITDA or its related term are showing as below:
FRA:4WK'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.57 Med: 5.77 Max: 10.37
Current: 9.16
During the past 12 years, the highest Debt-to-EBITDA Ratio of Wenzhou Kangning Hospital Co was 10.37. The lowest was 1.57. And the median was 5.77.
FRA:4WK's Debt-to-EBITDA is ranked worse than 88.75% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs FRA:4WK: 9.16
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Wenzhou Kangning Hospital Co Debt-to-EBITDA Related Terms
Wenzhou Kangning Hospital Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4WK vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Wenzhou Kangning Hospital Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wenzhou Kangning Hospital Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wenzhou Kangning Hospital Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wenzhou Kangning Hospital Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Jun. 2026) EBITDA data.
Wenzhou Kangning Hospital Co (FRA:4WK) has a Debt-to-EBITDA of 10.93 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Wenzhou Kangning Hospital Co. This is 89% above median its historical median of 5.77. Over the past decade, Wenzhou Kangning Hospital Co's Debt-to-EBITDA has ranged from 1.57 to 10.37. According to the industry distribution chart, Wenzhou Kangning Hospital Co ranks #426 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 88.7%.
Is Wenzhou Kangning Hospital Co's Debt-to-EBITDA too high?
Wenzhou Kangning Hospital Co's current Debt-to-EBITDA of 10.93 is 89% above median its 10-year median of 5.77. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 10.37. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Wenzhou Kangning Hospital Co's value of 10.93 is 400.2% above this industry median. Based on the distribution chart, Wenzhou Kangning Hospital Co ranks #426 out of 480 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Wenzhou Kangning Hospital Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Wenzhou Kangning Hospital Co's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wenzhou Kangning Hospital Co ranks #426 out of 480 companies for Debt-to-EBITDA. This places Wenzhou Kangning Hospital Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Wenzhou Kangning Hospital Co's value of 10.93 is 400.2% above this benchmark. Historically, Wenzhou Kangning Hospital Co's own Debt-to-EBITDA has ranged from 1.57 to 10.37 over the past decade. While the company's 10-year median is 5.77 vs. the industry median of 2.19, Wenzhou Kangning Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wenzhou Kangning Hospital Co's current Debt-to-EBITDA of 10.93 is 400.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Wenzhou Kangning Hospital Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wenzhou Kangning Hospital Co's current Debt-to-EBITDA is 10.93, which is 89% above median its own 10-year median of 5.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wenzhou Kangning Hospital Co stock overvalued right now?
Wenzhou Kangning Hospital Co (FRA:4WK) has a current Debt-to-EBITDA of 10.93. The stock's GF Value™ is €1.35, compared to a current price of €0.94 — trading 30.7% below its estimated fair value. The current Debt-to-EBITDA is 10.93, which is 89% above median its 10-year median of 5.77 and 400.2% above the Healthcare Providers & Services industry median of 2.19. Wenzhou Kangning Hospital Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Wenzhou Kangning Hospital Co (FRA:4WK), the current Debt-to-EBITDA is 10.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wenzhou Kangning Hospital Co (FRA:4WK) Overvalued in 2026?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co stock appears to be undervalued.
The current stock price of €0.94 is trading 30.7% below its estimated GF Value™ of €1.35.
Key valuation signals for FRA:4WK:
Debt-to-EBITDA: 10.93 (89% above median its 10-year median of 5.77)
GF Value™: €1.35 vs. price of €0.94 (30.7% below fair value)
Industry Position: 400.2% above the Healthcare Providers & Services median (#426 of 480)
No single metric tells the full story. See the FRA:4WK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wenzhou Kangning Hospital Co Ltd is engaged in operating a network of healthcare facilities that focus on providing psychiatric specialty care and elderly rehabilitation service across various regions in China. It derives revenue from operating its owned hospitals consists of fees charged for outpatient visits and inpatient services at the group's various hospitals, which can be divided into treatment and general healthcare services and pharmaceutical sales, as well as variable considerations for medical services provided by the group, mainly including medical insurance settlement differences.
75GF Score
Get the complete analysis for FRA:4WK
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4WK has been successfully added to your 
